A platform for research: civil engineering, architecture and urbanism
A platform for research: civil engineering, architecture and urbanism
Quinazoline analogs as receptor tyrosine kinase inhibitors
This invention provides quinazoline analogs of Formula (I): where A is bonded to at least one of the carbons at the 5, 6, 7 or 8 position of the bicyclic ring, and the ring is substituted by up to two independent R 3 groups. The invention also includes methods of using compounds of Formula (I) as type I receptor tyrosine kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
Quinazoline analogs as receptor tyrosine kinase inhibitors
This invention provides quinazoline analogs of Formula (I): where A is bonded to at least one of the carbons at the 5, 6, 7 or 8 position of the bicyclic ring, and the ring is substituted by up to two independent R 3 groups. The invention also includes methods of using compounds of Formula (I) as type I receptor tyrosine kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
Quinazoline analogs as receptor tyrosine kinase inhibitors
WALLACE ELI (author) / TOPALOV GEORGE (author) / LYSSIKATOS JOSEPH (author) / BUCKMELTER ALEXANDRE (author) / ZHAO QIAN (author)
2017-06-13
Patent
Electronic Resource
English
QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS
| European Patent Office | 2021
Quinazoline analogs as receptor tyrosine kinase inhibitors
| European Patent Office | 2019
QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS
| European Patent Office | 2019
QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS
| European Patent Office | 2017
Signal Transduction by EGF Receptor Tyrosine Kinase
| British Library Conference Proceedings | 1997